Dodoviscin ICAS# 1372527-40-6 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1372527-40-6 | SDF | Download SDF |
| PubChem ID | 57408289 | Appearance | Yellow powder |
| Formula | C21H22O7 | M.Wt | 386.4 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5,7-dihydroxy-2-[4-hydroxy-3-(4-hydroxy-3-methylbutyl)phenyl]-3-methoxychromen-4-one | ||
| SMILES | CC(CCC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC)O)CO | ||
| Standard InChIKey | LMOYOATYLHNKNP-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C21H22O7/c1-11(10-22)3-4-12-7-13(5-6-15(12)24)20-21(27-2)19(26)18-16(25)8-14(23)9-17(18)28-20/h5-9,11,22-25H,3-4,10H2,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
The herbs of Dodonaea viscosa
| Description | 1. Dodoviscin I can promote adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. |
| Targets | GLUT |
Dodoviscin I Dilution Calculator
Dodoviscin I Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.588 mL | 12.94 mL | 25.8799 mL | 51.7598 mL | 64.6998 mL |
| 5 mM | 0.5176 mL | 2.588 mL | 5.176 mL | 10.352 mL | 12.94 mL |
| 10 mM | 0.2588 mL | 1.294 mL | 2.588 mL | 5.176 mL | 6.47 mL |
| 50 mM | 0.0518 mL | 0.2588 mL | 0.5176 mL | 1.0352 mL | 1.294 mL |
| 100 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.5176 mL | 0.647 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Featured Products
- Dodoviscin H
Catalog No.:BCN3918
CAS No.:1372527-39-3
- Dodoviscin A
Catalog No.:BCN3927
CAS No.:1372527-25-7
- Voriconazole
Catalog No.:BCC2275
CAS No.:137234-62-9
- Sodium Orthovanadate
Catalog No.:BCC3856
CAS No.:13721-39-6
- Spinorphin
Catalog No.:BCC2349
CAS No.:137201-62-8
- Toddalosin
Catalog No.:BCN6194
CAS No.:137182-37-7
- BETP
Catalog No.:BCC6286
CAS No.:1371569-69-5
- (±)-Marmesin
Catalog No.:BCN3618
CAS No.:13710-70-8
- Tolfenamic Acid
Catalog No.:BCC4438
CAS No.:13710-19-5
- Pimecrolimus
Catalog No.:BCC4703
CAS No.:137071-32-0
- Alprenolol hydrochloride
Catalog No.:BCC7490
CAS No.:13707-88-5
- PACAP 1-38
Catalog No.:BCC6962
CAS No.:137061-48-4
New Products
- Dodoviscin J
Catalog No.:BCN3945
CAS No.:1372527-42-8
- GSK2636771
Catalog No.:BCC4993
CAS No.:1372540-25-4
- Chlorantholide A
Catalog No.:BCN4835
CAS No.:1372558-33-2
- Chlorantholide B
Catalog No.:BCN4834
CAS No.:1372558-34-3
- Chlorantholide C
Catalog No.:BCN4837
CAS No.:1372558-35-4
- Chlorantholide E
Catalog No.:BCN4836
CAS No.:1372558-36-5
- Boc-Asp-OH
Catalog No.:BCC2609
CAS No.:13726-67-5
- Boc-Hyp-OH
Catalog No.:BCC3251
CAS No.:13726-69-7
- Boc-Glu(OtBu)-OH
Catalog No.:BCC3392
CAS No.:13726-84-6
- Boc-Gln-OH
Catalog No.:BCC3382
CAS No.:13726-85-7
- Pemetrexed
Catalog No.:BCC9115
CAS No.:137281-23-3
- 4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d]pyrimodin-5-yl)ethyl]benzoic acid
Catalog No.:BCC8670
CAS No.:137281-39-1
Isoprenylated flavonoid and adipogenesis-promoting constituents of Dodonaea viscosa.[Pubmed:22512738]
J Nat Prod. 2012 Apr 27;75(4):699-706.
Ten new isoprenylated flavonol derivatives, dodoviscins A-J (1-10), and seven known compounds (11-17) were isolated from the aerial parts of Dodonaea viscosa. Compounds 1, 2, 4, 5, 7-9, 5,7,4'-trihydroxy-3',5'-bis(3-methyl-2-buten-1-yl)-3-methoxyflavone (11), 5,7,4'-trihydroxy-3',5'-bis(3-methyl-2-buten-1-yl)-3,6-dimethoxyflavone (12), 5,7,4'-trihydroxy-3'-(4-hydroxy-3-methylbutyl)-5'-(3-methyl-2-buten-1-yl)-3,6-dim ethyoxyflavone (13), sakuranetin (14), and blumeatin (15) promoted adipocyte differentiation as characterized by increased triglyceride levels in 3T3L1 cells. Compounds 1, 13, and 15 also enhanced the accumulation of lipid droplets and induced upregulation of the expression of the adipocyte-specific genes aP2 and GLUT4.
Dodoviscin I,1372527-40-6,Natural Products, buy Dodoviscin I , Dodoviscin I supplier , purchase Dodoviscin I , Dodoviscin I cost , Dodoviscin I manufacturer , order Dodoviscin I , high purity Dodoviscin I
